Mol Med. 2026 Mar 28;32(1):45. doi: 10.1186/s10020-025-01420-1.
NO ABSTRACT
PMID:41904401 | DOI:10.1186/s10020-025-01420-1
Categories
CD4 T-cell platform for delivering interferons as an antiviral countermeasure with a focus on SARS-CoV-2
